Findings may help with decision-making in this high-risk patient population.
Your search for Warfarin returned 4 results
The patients, a 71-year-old male and a 62 year-old-male, both on long-term warfarin therapy, presented to the emergency department with symptoms of COVID-19.
Study findings revealed an increased risk of surgical intervention in women exposed to rivaroxaban.
The patient developed a generalized maculopapular rash approximately 3 hours after receiving warfarin.